Marna whittington biography of georgetown

Marna whittington biography of georgetown: In Council member Dr.

Whittington is a member of the board of directors for Phillips She serves on the audit and finance, nominating and governance and public policy and sustainability committees. Whittington served as the Chief Executive Officer of Allianz Global Investors Capital, a global investment management firm, from until her retirement in January Whittington also serves on the board of directors of Ocugen, Inc.

She earned a Ph. To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time. Skip to main content. Close the mobile navigation.

Business Operations Return one level in the navigation. Business Operations Operations Return one level in the navigation. Operations Refining Midstream Return one level in the navigation. From until her retirement in January she was chief executive officer of Allianz Global Investors Capital, a successor firm of Nicholas Applegate Capital Management.

Allianz Global Investors Capital is a diversified global investment firm. Whittington was chief operating officer of Allianz Global Investors, the parent company of Allianz Global Investors Capital, from to Prior to joining Nicholas Applegate inDr. Whittington was managing director and chief operating officer of Morgan Stanley Investment Management.

Earlier, she had been first, budget director, and later, secretary of finance, for the State of Delaware. Director at Ocugen.

Marna whittington biography of georgetown: Marna C. Whittington has many years

Collingsworth served on the board of Premera Blue Cross. Bob obtained a B. Vajzovic is a vitreoretinal surgeon and tenured Associate Professor of Ophthalmology at Duke University School of Medicine with expertise in adult and pediatric retinal diseases and surgery. Vajzovic is passionate about translational research and collaborates closely with Duke biomedical engineers to develop imaging devices to improve ophthalmic care.

She serves as a principal investigator for numerous national clinical trials in early to late stages of development. In addition, she is interested in cutting-edge technologies and recovery of vision in hereditary and common retinal diseases with gene therapy, stem cell technology, and retinal implants. She is a co-director of the Duke Pediatric Retina and Optic Nerve Center, where she performs gene therapy delivery, and device implantation to restore vision to individuals with total blindness.

An influential educator, she organizes and directs several highly successful national and international courses, including the first-of-its-kind Advances in Pediatric Retina Course at Duke and the international Duke fellows and general Advances in Vitreous Surgery Course. Boyer is a world-renowned clinician, surgeon and educator. His areas of specialty include the treatment of diseases of the retina and vitreous.

He is currently a leading investigator for various national clinical trials on retinal diseases and serves as an advisor for multiple research, educational and charitable institutions. He received a B. In he finished his residency at the U. County Medical Center. Subsequently, he completed a year long retinal surgery fellowship at the Wills Eye Hospital, located in Philadelphia.

He received his medical degree from Harvard Medical School and performed his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital. He has been the principal investigator of numerous major clinical trials developing new medical and surgical treatments for retinal disorders such as macular degeneration and diabetic retinopathy and has authored more than publications along with over 30 book chapters and nine major books.

He is invited to lecture worldwide and serves on the scientific editorial board for several top ophthalmology peer-reviewed journals. He was also selected as a Charter Inductee of the Retina Hall of Fame and named to the Ophthalmologist Power List Top most influential people in the world of ophthalmology. Lalwani is the founder of Rocky Mountain Retina Associates, where she specializes in the medical and surgical treatment of retinal diseases.

Prior to founding Rocky Mountain Retina, Dr. Lalwani completed her fellowship in vitreoretinal surgery at the Bascom Palmer Eye Institute, and ophthalmology residency at Case Western Reserve, and received her M. Satish started his biotech career at Apollon, Inc. He is a biotechnology veteran with nearly 30 years of leadership positions. Over the last 30 years, his career in biological research and development has spanned across academia and industry; early start up and mid-stage biotech companies and in large pharmaceutical companies.

Marna whittington biography of georgetown: Marna started in the investment management

He is currently on the Board of Directors and serves as scientific advisor and consultant to several biotechnology companies. He is doing groundbreaking work to advance precision medicine for Castleman disease, a condition that he is battling as a physician, researcher, advocate, and patient. Combining omic technologies with machine learning and other bioinformatic tools, Dr.

Fajgenbaum has discovered novel predictive biomarkers of treatment response and novel treatment approaches, including one that is saving his life and others. For over 25 years, Dr. Forrest worked as a pharmaceutical industry physician leading the global development of pharmaceuticals, vaccines, and biological drugs. Forrest was responsible for management and oversight of all Vaccines Clinical Research clinical trial and development activities globally with a dedicated vaccines clinical staff.

He joined United Biomedical, Inc. She was involved in advancing multiple product candidates into the clinic and market including several first-in-man compounds. She received her Ph. He was a member of the U. Rubin is the founder of Energize the Chain a non-profit organization and GAVI INFUSE and funded partner that ensures the delivery of vaccines to people in the most remote regions of the world by utilizing power and connectivity in the private sector, such as that available at cell tower sites to power the refrigeration systems that are necessary to keep vaccines at the proper temperature.

She has worked on many aspects of coronavirus replication and pathogenesis over the last forty years, making contributions to understanding the basic biology as well as organ tropism and virulence. Her work for the last ten years has focused on coronavirus interaction with the host innate immune response and viral innate antagonists of double-stranded RNA induced antiviral pathways.

Her other research interests include activation and antagonism of the antiviral oligoadenylate-ribonuclease L OAS-RNase L pathway, flavivirus- primarily Zika- virus-host interactions and pathogenic effects of host endogenous dsRNA. Home About Our People. Tiffany J. Kristen Craft Head of People and Culture. Board of directors. Kirsten M. Castillo Director.

Prabhavathi FernandesPhD Director. WhittingtonPhD Director.